Correlation Between Alphabet and Marker Therapeutics
Can any of the company-specific risk be diversified away by investing in both Alphabet and Marker Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alphabet and Marker Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alphabet Inc Class C and Marker Therapeutics, you can compare the effects of market volatilities on Alphabet and Marker Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alphabet with a short position of Marker Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alphabet and Marker Therapeutics.
Diversification Opportunities for Alphabet and Marker Therapeutics
0.48 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Alphabet and Marker is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Alphabet Inc Class C and Marker Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Marker Therapeutics and Alphabet is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alphabet Inc Class C are associated (or correlated) with Marker Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Marker Therapeutics has no effect on the direction of Alphabet i.e., Alphabet and Marker Therapeutics go up and down completely randomly.
Pair Corralation between Alphabet and Marker Therapeutics
Given the investment horizon of 90 days Alphabet Inc Class C is expected to generate 0.27 times more return on investment than Marker Therapeutics. However, Alphabet Inc Class C is 3.65 times less risky than Marker Therapeutics. It trades about -0.02 of its potential returns per unit of risk. Marker Therapeutics is currently generating about -0.07 per unit of risk. If you would invest 17,269 in Alphabet Inc Class C on September 1, 2024 and sell it today you would lose (220.00) from holding Alphabet Inc Class C or give up 1.27% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Alphabet Inc Class C vs. Marker Therapeutics
Performance |
| Timeline |
| Alphabet Class C |
| Marker Therapeutics |
Alphabet and Marker Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Alphabet and Marker Therapeutics
The main advantage of trading using opposite Alphabet and Marker Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alphabet position performs unexpectedly, Marker Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Marker Therapeutics will offset losses from the drop in Marker Therapeutics' long position.The idea behind Alphabet Inc Class C and Marker Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Marker Therapeutics vs. Lumos Pharma | Marker Therapeutics vs. Exicure | Marker Therapeutics vs. Protagenic Therapeutics | Marker Therapeutics vs. Pmv Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |